Stoke Therapeutics, Inc. (STOK) Earnings
|
Expand Research on STOK
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +587.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +4.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/26  |
Q425 | N/A | -$0.73 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 11/4/25 | Q325 | -$0.65 | -$0.58 | -$0.07 | $10.63M | $6.06M | N/A |  | | Details | |
| 8/12/25 | Q225 | -$0.40 | -$0.50 | +$0.10 | $13.82M | $9.39M | N/A | | | Details | |
| 5/12/25 |
Q125 | $1.90 | $0.08 | +$1.82 | $158.57M | $27.66M | N/A | | | Details | |
| 3/18/25 | Q424 | -$0.18 | -$0.55 | +$0.37 | $22.61M | $4.1M | N/A | | | Details | |
| 3/17/25 |
Q424 | N/A | -$0.55 | N/A | N/A | $4.1M | N/A | N/A | N/A | ||
| 3/10/25 |
Q424 | N/A | -$0.55 | N/A | N/A | $4.1M | N/A | N/A | N/A | ||
| 3/7/25 |
Q424 | N/A | -$0.55 | N/A | N/A | $4.1M | N/A | N/A | N/A |
